Table 1 Baseline demographic of in Non-AF and AF group (N = 114)
Variable | Non-AF (n = 61) | AF (n = 53) | P-value |
|---|---|---|---|
Demographics | |||
Age (years) | 55.15 ± 11.01 | 64.00 ± 9.38 | < 0.001 |
Females (n, %) | 25 (41.0) | 24 (45.3) | 0.644 |
Height (m) | 1.66 ± 0.08 | 1.66 ± 0.08 | 0.619 |
Weight (kg) | 66.16 ± 11.89 | 66.07 ± 12.15 | 0.965 |
BMI (kg/m2) | 23.97 ± 3.21 | 23.74 ± 3.38 | 0.711 |
Medical history (n, %) | |||
Hypertension | 21 (34.4) | 24 (45.3) | 0.237 |
Diabetes mellitus | 6 (9.8) | 9 (17.0) | 0.260 |
Heart failure | 14 (23.0) | 13 (24.5) | 0.843 |
Stroke | 2 (3.3) | 1 (1.9) | 0.643 |
Coronary artery disease | 0 (0.0) | 5 (9.4) | 0.014 |
Vascular disease | 3 (4.9) | 5 (9.4) | 0.346 |
Pulmonary embolism | 0 (0.0) | 1 (1.9) | 0.285 |
Hyperthyroidism | 0 (0.0) | 1 (1.9) | 0.285 |
Renal dysfunction | 0 (0.0) | 1 (1.9) | 0.285 |
Hepatic dysfunction | 1 (1.8) | 5 (9.4) | 0.076 |
Current drinking | 17 (27.9) | 13 (24.5) | 0.686 |
Current smoking | 1 (1.6) | 2 (3.8) | 0.090 |
CHA2DS2-VASc score | 1 (1–2.5) | 2 (1–3) | 0.001 |
Medication, n (%) | |||
Oral anticoagulant | 1 (1.6) | 21 (39.6) | < 0.001 |
Antiplatelet drug | 1 (1.6) | 11 (20.8) | 0.001 |
ACEI/ARBs | 14 (23.0) | 14 (26.4) | 0.668 |
CCB | 7 (11.7) | 18 (34.0) | 0.004 |
Diuretic | 0 (0.0) | 8 (15.1) | 0.002 |
Digoxin | 0 (0.0) | 10 (19.2) | < 0.001 |
Beta-blocker | 3 (4.9) | 28 (52.8) | < 0.001 |
Amiodarone | 1 (1.6) | 5 (9.4) | 0.063 |